Latest Articles
and poor overall patient survival in - ResearchGate
and poor overall patient survival in ResearchGate
Published: May 11, 2025, 2:51 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature
Published: May 10, 2025, 10:19 a.m.
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer - OncLive
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer OncLive
Published: May 9, 2025, 11:26 p.m.
Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report.
Patients with ulcerative colitis (UC) are at an increased risk of colorectal cancer (CRC), which is compounded in the presence of other risk factors such as primary sclerosing cholangitis (PSC) …
Published: May 9, 2025, midnight
A Brand New Endometriosis Research Center Is Opening—Here’s How It’s Going to Help Patients - Yahoo
A Brand New Endometriosis Research Center Is Opening—Here’s How It’s Going to Help Patients Yahoo
Published: May 8, 2025, 4:17 p.m.
When doctors don't believe their patients' pain—experts explain the all-too-common experience of medical gaslighting - Medical Xpress
When doctors don't believe their patients' pain—experts explain the all-too-common experience of medical gaslighting Medical Xpress
Published: May 8, 2025, 2:20 p.m.
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting - The Conversation
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting The Conversation
Published: May 8, 2025, 12:34 p.m.
NHS patients to access Theramex’s endometriosis pill following NICE recommendation - PMLiVE
NHS patients to access Theramex’s endometriosis pill following NICE recommendation PMLiVE
Published: May 2, 2025, 11:13 a.m.
'I'm a dietician for cancer patients - five common mistakes are made after diagnosis' - The Mirror
'I'm a dietician for cancer patients - five common mistakes are made after diagnosis' The Mirror
Published: May 2, 2025, 9:06 a.m.
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.
To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis.
Published: May 2, 2025, midnight
Link copied to clipboard!